Janney Montgomery Scott LLC Sells 9,522 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

Janney Montgomery Scott LLC trimmed its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 24.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,927 shares of the biotechnology company's stock after selling 9,522 shares during the period. Janney Montgomery Scott LLC's holdings in Axon Enterprise were worth $15,214,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Fourth Dimension Wealth LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $30,000. Elequin Capital LP purchased a new position in Axon Enterprise during the 4th quarter valued at about $46,000. CoreFirst Bank & Trust purchased a new position in Axon Enterprise during the 4th quarter valued at about $59,000. Global Financial Private Client LLC lifted its position in Axon Enterprise by 11,100.0% during the 1st quarter. Global Financial Private Client LLC now owns 112 shares of the biotechnology company's stock valued at $59,000 after acquiring an additional 111 shares during the period. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new position in Axon Enterprise during the 1st quarter valued at about $77,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 0.8%

Axon Enterprise stock traded up $6.53 during trading hours on Friday, hitting $777.32. The stock had a trading volume of 1,181,999 shares, compared to its average volume of 476,402. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $60.51 billion, a P/E ratio of 187.76, a price-to-earnings-growth ratio of 88.73 and a beta of 1.29. Axon Enterprise, Inc has a 12-month low of $279.02 and a 12-month high of $806.64. The stock's 50-day moving average price is $687.97 and its 200-day moving average price is $625.39.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same period in the previous year, the business posted $1.15 earnings per share. The business's revenue for the quarter was up 31.3% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AXON has been the subject of a number of recent research reports. Barclays lifted their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research report on Thursday, May 8th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Finally, Bank of America lifted their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 905 shares of the business's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now directly owns 268,735 shares in the company, valued at approximately $208,643,166.65. The trade was a 0.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Brittany Bagley sold 3,400 shares of the business's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the sale, the chief financial officer now owns 131,833 shares of the company's stock, valued at $92,283,100. This trade represents a 2.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,642 shares of company stock worth $30,500,428 over the last three months. 4.40% of the stock is currently owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.